LyondellBasell Industries N.V.

- No new fundraising through debt or equity was announced in the call. - The company focused on protecting its investment-grade balance sheet and improving financial flexibility. - Actions include a 50% reduction in the quarterly dividend to rebalance capital allocation. - LYB plans to repay 2026 and 2027 debt maturities that were prefunded in 2025. - The company will only proceed with new investments when the balance sheet and outlook are more secure. - The emphasis remains on capital discipline and cash improvement rather than raising new funds.

- Modest investments planned in Hyperzone reliability and acetyls debottlenecks to deliver incremental value. - Construction on MoReTec-1 continues as planned with ramp-up expected toward end of 2027, projected to increase EBITDA by ~$400 million. - Near-term focus remains on investing in safe and reliable operations. - Capital allocation priorities emphasize disciplined capital spending and balance sheet strength. - Several attractive projects ready for investment, but will proceed only when balance sheet and outlook are more secure. - Sale of 4 European assets completed to sharpen capital allocation focus on strategic assets for long-term value creation. - Continued emphasis on MoReTec investments and polypropylene joint venture expansion in Saudi Arabia (second phase to double capacity).

- Technology segment expects improved results in Q2 due to licensing milestones and shipment timing. - Polymer margins and volumes are improving; operating rates to increase to ~80% across the segment in Q2. - Advanced Polymer Solutions (APS) segment is seeing volume increases driven by seasonal demand and customer focus, though margins face raw material cost pressures. - Intermediates and Derivatives segment targeting ~75% operating rates in Q2, expecting improved volumes and margins from seasonal recovery and restarts. - Polypropylene business anticipated to turn positive with increased operating rates (70-75% current to higher) and tightening global supply due to Strait of Hormuz impact. - Long-term growth projects (e.g., MoReTec-1 expected ramp-up end of 2027) aim to add ~$400 million EBITDA. - Overall, supply disruptions and regional dynamics are supporting better pricing and demand, with cautious optimism for volume and revenue growth over 2-4 years.

- Future growth projects (e.g., MoReTec-1) expected to ramp up by end of 2027, adding ~$400 million EBITDA. - Higher second-quarter margins and volumes anticipated due to global supply tightness and strong order books. - Operating rates targeted around 75% (I&D segment) to 90% (O&P Americas segment) in Q2. - Passing through higher raw material and energy costs expected while maintaining profitability. - Improved Technology segment results forecasted in Q2 due to shipment timing and licensing milestones. - European portfolio transformation and asset sale to reduce fixed costs (~EUR 400 million annually) and improve mid-cycle EBITDA margins to 21%+. - Capital allocation focus remains on investment-grade balance sheet, safe operations, and cash improvement plan. - Cautious near-term demand outlook in automotive and durable goods but packaging demand remains robust; no current evidence of demand destruction.

- Licensing activity declined in Q1 due to slower global polyolefins capacity growth and lower catalyst sales tied to shipping constraints from the Middle East war. - Q2 expected to see improved Technology segment results as milestone shipments and licensing revenues increase. - Demand is at historically low levels, with some projects in "reserved status," delaying investments over the next 2-4 years. - Overall, orderbook/pending orders in licensing are lagging currently but anticipated to improve in Q2. - The delayed investments due to low licensing volumes in recent years mean fewer new projects will come online short term. - The company projects second quarter licensing to be better than Q1 but still facing headwinds due to geopolitical impacts.